跳至主要内容
临床试验/NL-OMON20962
NL-OMON20962尚未招募不适用

Assessment of Treatment with Laparoscopic fenestration or Aspiration Sclerotherapy for large symptomatic hepatic cysts (ATLAS): a randomized clinical trial.

Radboudumc0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Radboudumc
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age =18 years
  • Hepatic cyst characteristics:
  • oLarge (>5 cm),
  • oSymptomatic (PLD-Q score =20),
  • oNon-parasitic on imaging (US/CT/MRI)
  • oNon-neoplastic on imaging (US/CT/MRI)
  • Providing informed consent

排除标准

  • Clinical suspicion of a complicated hepatic cyst (cyst rupture or active cyst infection)
  • Cyst is not laparoscopically accessible for surgery
  • Cyst is not percutaneously (ultrasound-guided) accessible for aspiration
  • More than 20 cysts of >1.5 cm
  • Age above 70 years
  • ECOG score >1
  • Aspiration sclerotherapy or laparoscopic fenestration of hepatic cysts was performed in the last 6 months.
  • Severe renal impairment (eGFR < 30 ml/min/1,73 m2)
  • Coagulopathy (spontaneous INR >2 or platelet count < 80 x 109/l)
  • Radiologic contrast allergy
  • Any current or prior medical condition that may interfere with the conduct of the study or the evaluation of its results in the opinion of the investigator (e.g. inability to fill out questionnaires).

研究者

发起方
Radboudumc

相似试验